Femoral BMD Change Following Cemented or Cementless Total Knee Arthroplasty
Femoral Bone Mineral Density (BMD) Change Following Cemented or Cementless Total Knee Arthroplasty
3 other identifiers
interventional
100
1 country
1
Brief Summary
The purpose of this study is to examine femur bone mineral density (BMD) change before and after surgery in patients receiving cemented or cementless total knee arthroplasty (TKA). performed with manual or robotic methods. 100 participants will be enrolled and can expect to be on study for up to 26 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 10, 2024
CompletedFirst Posted
Study publicly available on registry
December 13, 2024
CompletedStudy Start
First participant enrolled
March 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2028
February 19, 2026
February 1, 2026
3.2 years
December 10, 2024
February 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Percent Change in Bone Mineral Density within 25 percent of the region of interest at 12 and 24 months post TKA: All Participants
Primary endpoint is to estimate percent BMD change 12 and 24 months after TKA at the distal femur, 25 percent region of interest, reported for all participants together.
12 months, 24 months
Percent Change in Bone Mineral Density within 25 percent of the region of interest at 12 and 24 months post TKA: Cemented vs Uncemented
Compare percent BMD change 12 and 24 months after TKA at the distal femur, 25 percent region of interest between all cemented and uncemented implants.
12 months, 24 months
Percent Change in Bone Mineral Density within 25 percent of the region of interest at 12 and 24 months post TKA: Robotic vs Manual
Compare percent BMD change 12 and 24 months after TKA at the distal femur, 25 percent region of interest between all robotic vs manual implants.
12 months, 24 months
Secondary Outcomes (3)
Percent Change in Bone Mineral Density within 15 percent of the region of interest at 12 and 24 months post TKA: All Participants
12 months, 24 months
Percent Change in Bone Mineral Density within 15 percent of the region of interest at 12 and 24 months post TKA: Cemented vs Uncemented
12 months, 24 months
Percent Change in Bone Mineral Density within 15 percent of the region of interest at 12 and 24 months post TKA: Robotic vs Manual
12 months, 24 months
Other Outcomes (6)
Visual Analog Scale (VAS) for Patient Reported Pain
2 weeks, 3 months, 12 months, 24 months
Patient Reported Function measured by the Oxford Knee Score (OKS)
2 weeks, 3 months, 12 months, 24 months
Patient Reported Function measured by the Koos Jr Knee Survey
2 weeks, 3 months, 12 months, 24 months
- +3 more other outcomes
Study Arms (4)
Cemented and Manual
ACTIVE COMPARATORCemented and Robotic
ACTIVE COMPARATORCementless and Manual
ACTIVE COMPARATORCementless and Robotic
ACTIVE COMPARATORInterventions
The cemented approach includes inserting cement into the femur and tibia prior to setting the prosthetic.
The non-cement approach uses a different type of prosthetic that is placed tight against the bone and requires no other fixation material.
The manual approach is the surgeon determining prosthetic placement using techniques developed during training.
The haptic robotic assisted approach uses a computer and robot to determine specific placement of the prosthetic.
Eligibility Criteria
You may qualify if:
- Patients age greater than or equal to 55 years undergoing TKA with no prior total joint arthroplasty on the surgical side
- Normal BMD or osteopenia with Fracture Risk Assessment Tool (FRAX) not meeting Bone Health and Osteoporosis Foundation (BHOF) treatment recommendations, i.e., 10-year major osteoporotic fracture risk greater then or equal to 20 percent or hip fracture risk greater than or equal to 3 percent.
You may not qualify if:
- Known clinical osteoporosis defined as any one of the following:
- Hip or spine T-score less than or equal to -2.5
- History of low trauma fracture after age 50
- FRAX fracture risk calculation greater than or equal to 20 percent for major osteoporotic fracture or greater than or equal to 3 percent for hip fracture
- Prior or current use of osteoporosis medications
- Current use of systemic glucocorticoids or bone-active medications
- Rheumatoid arthritis
- Laboratory abnormalities that in the opinion of study investigators may impact bone mineral density; including calcium, creatinine, albumin and parathyroid hormone (PTH)
- (OH)D less than 20 ng/mL
- Not suitable for study participation due to other reasons at the investigator's discretion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UW School of Medicine and Public Health
Madison, Wisconsin, 53792, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brian Nickel, MD
UW School of Medicine and Public Health
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 10, 2024
First Posted
December 13, 2024
Study Start
March 6, 2025
Primary Completion (Estimated)
June 1, 2028
Study Completion (Estimated)
June 1, 2028
Last Updated
February 19, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share